Italy · Delayed Price · Currency is EUR Madrigal Pharmaceuticals Statistics
Total Valuation
BIT:1MDGL has a market cap or net worth of EUR 7.11 billion. The enterprise value is 6.53 billion.
| Market Cap | 7.11B |
| Enterprise Value | 6.53B |
Important Dates
The last earnings date was Tuesday, August 5, 2025.
| Earnings Date | Aug 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 22.29M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +10.46% |
| Shares Change (QoQ) | +0.52% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 11.04M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 16.19 |
| PB Ratio | 11.99 |
| P/TBV Ratio | 12.07 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -27.21 |
| EV / Sales | 14.84 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -24.87 |
Financial Position
The company has a current ratio of 5.11, with a Debt / Equity ratio of 0.18.
| Current Ratio | 5.11 |
| Quick Ratio | 4.46 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.40 |
| Interest Coverage | -22.55 |
Financial Efficiency
Return on equity (ROE) is -36.30% and return on invested capital (ROIC) is -21.57%.
| Return on Equity (ROE) | -36.30% |
| Return on Assets (ROA) | -18.31% |
| Return on Invested Capital (ROIC) | -21.57% |
| Return on Capital Employed (ROCE) | -37.83% |
| Revenue Per Employee | 831,417 |
| Profits Per Employee | -454,616 |
| Employee Count | 528 |
| Asset Turnover | 0.49 |
| Inventory Turnover | 0.54 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 94.98 |
| Average Volume (20 Days) | 1 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 11.16 |
Income Statement
In the last 12 months, BIT:1MDGL had revenue of EUR 438.99 million and -240.04 million in losses. Loss per share was -10.91.
| Revenue | 438.99M |
| Gross Profit | 422.66M |
| Operating Income | -263.81M |
| Pretax Income | -240.04M |
| Net Income | -240.04M |
| EBITDA | -262.60M |
| EBIT | -263.81M |
| Loss Per Share | -10.91 |
Balance Sheet
The company has 678.67 million in cash and 105.54 million in debt, giving a net cash position of 573.12 million.
| Cash & Cash Equivalents | 678.67M |
| Total Debt | 105.54M |
| Net Cash | 573.12M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 592.63M |
| Book Value Per Share | 26.67 |
| Working Capital | 687.04M |
Cash Flow
In the last 12 months, operating cash flow was -261.76 million and capital expenditures -829,361, giving a free cash flow of -262.59 million.
| Operating Cash Flow | -261.76M |
| Capital Expenditures | -829,361 |
| Free Cash Flow | -262.59M |
| FCF Per Share | n/a |
Margins
Gross margin is 96.28%, with operating and profit margins of -60.09% and -54.68%.
| Gross Margin | 96.28% |
| Operating Margin | -60.09% |
| Pretax Margin | -54.68% |
| Profit Margin | -54.68% |
| EBITDA Margin | -59.82% |
| EBIT Margin | -60.09% |
| FCF Margin | n/a |
Dividends & Yields
BIT:1MDGL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.46% |
| Shareholder Yield | n/a |
| Earnings Yield | -3.38% |
| FCF Yield | -3.70% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BIT:1MDGL has an Altman Z-Score of 9.73 and a Piotroski F-Score of 2.
| Altman Z-Score | 9.73 |
| Piotroski F-Score | 2 |